These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2795686)

  • 1. Growth factor receptor monoclonal antibodies and cancer immunotherapy.
    Sato GH; Sato JD
    J Natl Cancer Inst; 1989 Nov; 81(21):1600-1. PubMed ID: 2795686
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.
    Mendelsohn J
    Prog Allergy; 1988; 45():147-60. PubMed ID: 3064094
    [No Abstract]   [Full Text] [Related]  

  • 3. EGF mutant receptor vIII as a molecular target in cancer therapy.
    Kuan CT; Wikstrand CJ; Bigner DD
    Endocr Relat Cancer; 2001 Jun; 8(2):83-96. PubMed ID: 11397666
    [No Abstract]   [Full Text] [Related]  

  • 4. [New developments in immunotherapy for digestive system diseases].
    Imai K
    Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1901-7. PubMed ID: 16223155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].
    Larbouret C; Robert B; Teulon I; Azria D; Pèlegrin A
    Med Sci (Paris); 2007 Oct; 23(10):800-3. PubMed ID: 17937885
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic application of anti-growth factor receptor antibodies.
    Fan Z; Mendelsohn J
    Curr Opin Oncol; 1998 Jan; 10(1):67-73. PubMed ID: 9466487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies directed at growth factor receptors.
    Baselga J
    Ann Oncol; 2000; 11 Suppl 3():187-90. PubMed ID: 11079139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.
    Kawamoto T; Sato GH; Takahashi K; Nishi M; Taniguchi S; Sato JD
    Cytotechnology; 1990 May; 3(3):279-93. PubMed ID: 1366662
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic.
    Mendelsohn J
    Cancer Immunol Immunother; 2003 May; 52(5):342-6. PubMed ID: 12700950
    [No Abstract]   [Full Text] [Related]  

  • 10. Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study.
    Brady LW; Markoe AM; Woo DV; Amendola BE; Karlsson UL; Rackover MA; Koprowski H; Steplewski Z; Peyster RG
    Front Radiat Ther Oncol; 1990; 24():151-60; discussion 161-5. PubMed ID: 2160408
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficient production of monoclonal antibodies to the epidermal growth factor receptor.
    King I; Sartorelli AC
    J Immunol Methods; 1987 Oct; 103(1):153-4. PubMed ID: 2443577
    [No Abstract]   [Full Text] [Related]  

  • 12. Oligoclonal antibodies to target the ErbB family.
    D'Souza JW; Robinson MK
    Expert Opin Biol Ther; 2015 Jul; 15(7):1015-21. PubMed ID: 25936923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response.
    Hartmann C; Müller N; Blaukat A; Koch J; Benhar I; Wels WS
    Oncogene; 2010 Aug; 29(32):4517-27. PubMed ID: 20514015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and monoclonal antibody therapies.
    Schuster JM; Bigner DD
    Curr Opin Oncol; 1992 Jun; 4(3):547-52. PubMed ID: 1498162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.
    Capdevila J; Elez E; Macarulla T; Ramos FJ; Ruiz-Echarri M; Tabernero J
    Cancer Treat Rev; 2009 Jun; 35(4):354-63. PubMed ID: 19269105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
    Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
    Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and assay of biological effects of monoclonal antibodies to epidermal growth factor receptors.
    Sato JD; Le AD; Kawamoto T
    Methods Enzymol; 1987; 146():63-81. PubMed ID: 3500387
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinomas.
    Ohshio G; Shimada Y; Manabe T; Tobe T
    Cancer; 1990 May; 65(9):2102. PubMed ID: 2372776
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.
    Aboud-Pirak E; Hurwitz E; Bellot F; Schlessinger J; Sela M
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3778-81. PubMed ID: 2786202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.
    Costa R; Santa-Maria CA; Rossi G; Carneiro BA; Chae YK; Gradishar WJ; Giles FJ; Cristofanilli M
    Oncotarget; 2017 Feb; 8(7):12417-12432. PubMed ID: 27926493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.